Lobbying activity

Q1

COVINGTON & BURLING LLP for PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · $420,000.00 income

Copyright/Patent/Trademark, Health Issues

View → Q1

BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate

Agriculture, Animals, Budget/Appropriations, Chemicals/Chemical Industry

View → Q1

BIOGEN for BIOGEN

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate

Medicare/Medicaid, Pharmacy, Manufacturing, Trade (domestic/foreign)

View → Q1

WILLIAMS AND JENSEN, PLLC for PHRMA

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $50,000.00 income

Medicare/Medicaid, Health Issues, Budget/Appropriations, Defense

View → Q1

INTRA-CELLULAR THERAPIES, INC. for INTRA-CELLULAR THERAPIES, INC.

1st Quarter (Jan 1 - Mar 31) 2025 · New York · House · Senate

Medicare/Medicaid, Taxation/Internal Revenue Code

View → Q1

JOHNSON & JOHNSON SERVICES, INC. for JOHNSON & JOHNSON SERVICES INC

1st Quarter (Jan 1 - Mar 31) 2025 · New Jersey · House · Senate

Pharmacy, Science/Technology, Taxation/Internal Revenue Code, Veterans

View → Q1

PTC THERAPEUTICS, INC. for PTC THERAPEUTICS, INC.

1st Quarter (Jan 1 - Mar 31) 2025 · New Jersey · House · Senate

Health Issues, Medical/Disease Research/Clinical Labs, Medicare/Medicaid, Taxation/Internal Revenue Code

View → Q1

NOVARTIS for NOVARTIS

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate

Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid

View → Q1

LUNDBECK LLC for LUNDBECK LLC

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate

Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Trade (domestic/foreign)

View → Q1

MERCK & CO, INC. for MERCK & CO INC

1st Quarter (Jan 1 - Mar 31) 2025 · New Jersey · House · Senate

Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Animals

View → Q1

W STRATEGIES, LLC for SANOFI U.S. SERVICES, INC.

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · $50,000.00 income

Medicare/Medicaid

View → Q1

MARSHALL & POPP, LLC for SANOFI U.S. SERVICES, INC.

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income

Pharmacy, Copyright/Patent/Trademark, Trade (domestic/foreign), Taxation/Internal Revenue Code

View → Q1

MARSHALL & POPP, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $40,000.00 income

Pharmacy, Copyright/Patent/Trademark, Trade (domestic/foreign), Budget/Appropriations

View → Q1

MARSHALL & POPP, LLC for PFIZER, INC.

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income

Budget/Appropriations, Pharmacy, Copyright/Patent/Trademark, Trade (domestic/foreign)

View → Q1

MARSHALL & POPP, LLC for JAZZ PHARMACEUTICALS, INC. AND ITS SUBSIDIARIES, INCLUDING GREENWICH BIOSCIENCES

1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate · $40,000.00 income

Health Issues, Budget/Appropriations

View → Q1

MARSHALL & POPP, LLC for GENENTECH, INC.

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income

Pharmacy, Copyright/Patent/Trademark, Trade (domestic/foreign)

View → Q1

MARSHALL & POPP, LLC for AMGEN USA INC.

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income

Trade (domestic/foreign), Budget/Appropriations, Pharmacy, Copyright/Patent/Trademark

View → Q1

YC CONSULTING, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · $30,000.00 income

Health Issues

View → Q1

DESIMONE CONSULTING, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $30,000.00 income

Pharmacy

View → Q1

W STRATEGIES, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income

Medicare/Medicaid

View → Q1

W STRATEGIES, LLC for MERCK & CO., INC.

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · $50,000.00 income

Medicare/Medicaid, Health Issues

View → Q1

W STRATEGIES, LLC for GILEAD SCIENCES, INC.

1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate · $60,000.00 income

Health Issues, Medicare/Medicaid

View → Q1

W STRATEGIES, LLC for CALIFORNIA LIFE SCIENCES

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · $40,000.00 income

Medicare/Medicaid, Health Issues, Taxation/Internal Revenue Code

View → Q1

ACADIA PHARMACEUTICALS for ACADIA PHARMACEUTICALS

1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate

Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code

View → Q1

HARMONY BIOSCIENCES for HARMONY BIOSCIENCES

1st Quarter (Jan 1 - Mar 31) 2025 · Pennsylvania · House · Senate

Pharmacy

View →